A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy

INTRODUCTION: Combination therapy using immuno‐oncology drugs with tyrosine kinase inhibitors is increasingly important in the therapeutic strategy for metastatic renal cell carcinomas. Here, we report a case of metastatic renal cell carcinoma that was successfully treated with deferred cytoreductiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Hiroaki, Sazuka, Tomokazu, Fujimoto, Ayumi, Kagitani, Sakurako, Arai, Takayuki, Goto, Yusuke, Imamura, Yusuke, Sakamoto, Shinichi, Ikeda, Jun‐Ichiro, Ichikawa, Tomohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151202/
https://www.ncbi.nlm.nih.gov/pubmed/37144081
http://dx.doi.org/10.1002/iju5.12584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151202/
https://www.ncbi.nlm.nih.gov/pubmed/37144081
http://dx.doi.org/10.1002/iju5.12584

Ejemplares similares